Teliso-V (telisotuzumab vedotin) is pitching to become the first targeted cancer treatment for people with non-small cell lung cancer (NSCLC) whose tumours overexpress c-Met. The c-Met protein ...
Spotify Technology S.A. 1.42% $117.71B ...
After hours: March 19 at 4:34:30 PM EDT Loading Chart for CHRW ...
Data supplied by Morningstar and accurate on Sep 19, 2024. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback